Automatic sensor adjustment in a rate modulated pacemaker. North American Trilogy DR+ Phase I Clinical Investigators.

A new feature (AutoSlope) has been introduced that can automatically adjust the sensor slope based on the chronic activity level of the patient. The algorithm adjusts the slope once per week so that 99% of the sensor response is maintained between the base rate and 23% of the difference between the programmed Base Rate and the Max Sensor Rate. Offsets are available for fine titration of sensor response in individual patients. The AutoSlope feature was evaluated in 93 patients with DDDR pacemakers (Trilogy DR+, Pacesetter). Patients were seen at 1, 3, and 6 months for a total of 178 evaluations. At each evaluation, the AutoSlope value was recorded. Patients then performed a brisk walk at sensor values equivalent to the AutoSlope value. Desired sensor rate was compared to the rate achieved by AutoSlope for the exercise period. Longterm sensor performance was evaluated by analyzing the sensor histogram. AutoSlope provided the desired sensor rate in most patients. Use of AutoSlope offsets allows fine titration of rate modulation in individual patients. Ongoing changes in sensor performance provided by AutoSlope allow patients to achieve a desired sensor rate from one evaluation to another without changes in permanent programmed settings. Programming a low maximum sensor rate may limit sensor response in some patients.

The effects of electronic article surveillance systems on permanent cardiac pacemakers: an in vitro study.

UNLABELLED: Five Siemens Pacesetter cardiac pacemakers (PM) were subjected to in vitro testing with six different electronic article surveillance (EAS) devices. The PMs consisted of polarity programmable, dedicated bipolar, and dedicated unipolar types. EAS equipment included UHF, RF, Magnetic, and Magnetoacoustic (MA) devices from two manufacturers. Prior to testing, each PM was interrogated and normal operation confirmed. Each PM was attached to a heart simulator via an eight foot cable and then subjected to testing within the EAS field. The PMs were passed through the field in two axes, positioned stationary within the field, and, worst case (WC), placed directly against the transmitter. During testing the ECG was observed and PM behavior recorded. In one PM (Synchrony III), Event Records, and Event Histograms were utilized. At the conclusion of testing with each EAS device the PM was evaluated for normal operation. RESULTS: No PM was reprogrammed by the EAS devices. UHF produced no effect on the PMs. RF produced noise response in one unipolar PM while in the WC position. High frequency and multifrequency magnetic units produced positive results only in the WC position. Unipolar PMs were affected more often than bipolar. MA and older magnetic EAS units produced more positive responses than newer lower power devices. One incident of close coupled (400 msec) ventricular pacing was seen with the MA EAS unit. CONCLUSIONS: UHF, RF, high frequency, and dual frequency magnetic EAS produced few effects during in vitro testing. Except with the MA and low frequency magnetic devices, positive results occurred only in WC conditions.(ABSTRACT TRUNCATED AT 250 WORDS)